Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib with Chemotherapy in Newly Diagnosed Ph+ ALL
NCT00905398Phase 2Terminated
- Start
- May 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of nilotinib in acute lymphoblastic leukemia (ALL). Started May 2009; status: terminated.
02
Drugs
nilotinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00905398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00905398.